Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20269 Citations
Desmopressin (DDAVP) is an FDA-approved vasopressin analog prescribed for central diabetes insipidus, bedwetting, and mild hemophilia A. It replaces missing antidiuretic hormone and boosts clotting factors without blood transfusions. Effective across three distinct indications, though strict fluid restriction is required to prevent hyponatremia.
2mcg · Daily
Summary: Add 0mL BAC water to your 0.004mg vial. Draw to < 0.1 units on a U-100 syringe for a 2mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 2mcg | Daily |
| Moderate | 2mcg | 1-2x Daily |
| Aggressive | 4mcg | 1-2x Daily |
Desmopressin injectable comes ready to use at 4 mcg/mL. No reconstitution needed. Draw directly from the vial with an insulin syringe. For the standard DI dose of 2 mcg: that is 0.5 mL from the 4 mcg/mL vial, which reads as 50 units on a U-100 insulin syringe. A 4 mcg dose is 1.0 mL, or 100 units on the same syringe. Store vials refrigerated at 2 to 8 degrees Celsius. Room temperature (20 to 25 degrees) is fine for up to 3 weeks if needed, but don't freeze it. The biggest mistake new DI patients make is drinking out of habit. You've spent months or years guzzling water to keep up with polyuria. Once desmopressin kicks in, that habit becomes dangerous. Drink only when genuinely thirsty, nothing more. If you're switching from injectable to oral tablets, multiply your dose significantly. Oral bioavailability is 0.08 to 0.16 percent versus nearly 100 percent subcutaneous. Your doctor will recalculate, and sodium needs rechecking within a week.
Dosing based on DDAVP Injection FDA Prescribing Information (2022) — 11 published references.View all sources →
Cross-check your Desmopressin (DDAVP) reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Desmopressin (DDAVP) is an FDA-approved vasopressin analog prescribed for central diabetes insipidus, bedwetting, and mild hemophilia A. It replaces missing antidiuretic hormone and boosts clotting factors without blood transfusions. Effective across three distinct indications, though strict fluid restriction is required to prevent hyponatremia.